These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8020125)

  • 1. Agents for the treatment of overactive detrusor. VII. Synthesis and pharmacological properties of 2,3- and 3,4-diphenylcyclopentylamines, 2,3-diphenyl-2-cyclopentenylamines, and related compounds.
    Taniguchi K; Tsubaki K; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):896-902. PubMed ID: 8020125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine.
    Take K; Okumura K; Tsubaki K; Taniguchi K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1858-64. PubMed ID: 8904812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents for the treatment of overactive detrusor. VIII. Synthesis and pharmacological properties of 4,4-diphenyl-2-cycloalkenylamines including FK584 and 3,3- or 4,4-diphenylcycloalkylamines.
    Taniguchi K; Okumura K; Take K; Tsubaki K; Terai T; Nakanishi I; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):71-7. PubMed ID: 7895309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents for the treatment of overactive detrusor. VI. Synthesis and pharmacological properties of acetamide derivatives bearing cyclic amines in N-substituents.
    Taniguchi K; Tsubaki K; Mizuno H; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):74-84. PubMed ID: 8124770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents for the treatment of overactive detrusor. IX. Synthesis and pharmacological properties of metabolites of N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine (FK584) in human urine.
    Taniguchi K; Miyao Y; Yamano K; Yamamoto T; Terai T; Kusunoki T; Tsubaki K; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1996 Jun; 44(6):1188-95. PubMed ID: 8814950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agents for the treatment of overactive detrusor. III. Synthesis and structure-activity relationships of N-(4-amino-2-butynyl)acetamide derivatives.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1415-23. PubMed ID: 1394662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents for the treatment of overactive detrusor. I. Synthesis and structure-activity relationships of 1,1'-biphenyl derivatives.
    Take K; Okumura K; Takimoto K; Kato M; Ohtsuka M; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2915-23. PubMed ID: 1799939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents for the treatment of overactive detrusor. II. Synthesis and inhibitory activity on detrusor contraction of 1,1'-biphenyl-2,6-dicarboxylic acid diesters with an aminoalkyl group in the ester function.
    Take K; Okumura K; Takimoto K; Ohtsuka M; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):899-906. PubMed ID: 1525946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents for the treatment of overactive detrusor. IV. Synthesis and structure-activity relationships of cyclic analogues of terodiline.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):507-15. PubMed ID: 8477501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drugs used in the therapy of detrusor hyperactivity on the volume-induced contractions of the rat urinary bladder.
    Guarneri L; Ibba M; Angelico P; Colombo D; Fredella B; Testa R
    Pharmacol Res; 1993; 27(2):173-87. PubMed ID: 8474961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H
    J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRK-380, a novel selective human β3-adrenoceptor agonist, ameliorates formalin-induced pollakiuria in rats and carbachol-induced bladder contraction in dogs.
    Kanie S; Otsuka A; Yoshikawa S; Kobayashi R; Itaba S; Yokokawa H; Tajima Y; Ozono S; Hayashi R; Mochizuki H
    Urology; 2013 Oct; 82(4):975.e7-975.e12. PubMed ID: 24075004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.
    Sellers DJ; Chapple CR; W Hay DP; Chess-Williams R
    Eur Urol; 2006 Mar; 49(3):510-8. PubMed ID: 16420969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline.
    Smith ER; Wright SE; Aberg G; Fang Y; McCullough JR
    Arzneimittelforschung; 1998 Oct; 48(10):1012-8. PubMed ID: 9825119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of tolterodine on human isolated urinary bladder.
    Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
    Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum--a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome.
    Fürer K; Eberli D; Betschart C; Brenneisen R; De Mieri M; Hamburger M; Mennet-von Eiff M; Potterat O; Schnelle M; Simões-Wüst AP; von Mandach U
    Phytomedicine; 2015 Jan; 22(1):158-64. PubMed ID: 25636885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Izalpinin from fruits of Alpinia oxyphylla with antagonistic activity against the rat bladder contractility.
    Yuan Y; Tan YF; Xu P; Li H; Li YH; Chen WY; Zhang JQ; Chen F; Huang GJ
    Afr J Tradit Complement Altern Med; 2014; 11(4):120-5. PubMed ID: 25392590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
    Testa R; Guarneri L; Bernasconi P; Angelico P; Ibba M; Poggesi E; Meli A
    Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.